Brady Corp. (BRC) Tops Q4 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts BRC Hot Sheet
Price: $95.12 --0%
Revenue Growth %: +7.6%
Financial Fact:
Cost of products sold: 141.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Revenue Growth %: +7.6%
Financial Fact:
Cost of products sold: 141.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Brady Corp. (NYSE: BRC) reported Q4 EPS of $1.26, $0.03 better than the analyst estimate of $1.23. Revenue for the quarter came in at $397.28 million versus the consensus estimate of $386.68 million.
GUIDANCE:
Brady Corp. sees FY2026 EPS of $4.85-$5.15, versus the consensus of $4.58.
For earnings history and earnings-related data on Brady Corp. (BRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
